Louis Mosley, executive vice-chair of Palantir in the UK, has criticised what he called 'ideologically motivated campaigners' as government ministers explore triggering a break clause in the company's £330 million NHS contract. Mosley argued that ending the deal would harm patient care and prevent the NHS from tackling major challenges.
The contract involves Palantir's Federated Data Platform (FDP), an AI-enabled system designed to connect health data across the NHS. Mosley told the Times that the software is delivering benefits, forecasting £150 million in savings by the end of the decade, representing a £5 return for every pound spent. He urged the government to resist calls to eject the company from NHS England's data systems.
According to the Financial Times, ministers have sought advice on triggering a break clause in the FDP contract when it becomes active next year. Government officials argue it is feasible to transfer the platform to another provider. The British Medical Association (BMA) has long opposed Palantir's involvement in the NHS, citing concerns over patient data use.
Health officials have expressed fears that Palantir's reputation—stemming from its work with the US and Israeli militaries and Donald Trump's ICE operation—could affect delivery of the contract. Sources indicate that concerns about reputational risk have spread beyond Labour's left and the Greens.
A Department of Health and Social Care spokesperson defended the platform, stating it helps join up patient care and increase productivity, with strict data security requirements. Health Secretary Wes Streeting acknowledged ethical concerns about Palantir's leaders but stressed that the company does not see patient data. The number of NHS organisations using Palantir technology has risen to 151, still short of the target of 240 by year-end.
